Protalix Biotherapeutics Alternatives & Competitors
12 companies similar to Protalix Biotherapeutics — Pharmaceutical Commercialization and Development
Companies similar to Protalix Biotherapeutics
Acer Therapeutics Inc.
Focused on the acquisition, development & commercialization of therapies for serious rare...
Newton, United States
Sopherion Therapeutics
Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.
Outlook Therapeutics, Inc.
ONS-5010: A uniquely positioned anti-VEGF therapy for wet AMD, DME and BRVO
Cranbury, United States
South San Francisco, Unit...
Rival Readout
Competing with Protalix Biotherapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Akebia Therapeutics
We're focused on the development & commercialization of therapeutics for people living wit...
Cambridge, United States
Dublin, Ireland
Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoi...
Avillion Life Sciences
Accelerating global drug development through successful partnering for patient benefit
London, United Kingdom
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
San Diego, United States
VarmX
VarmX is a young biotech company focusing on the development of therapies in the field of...
Leiden, The Netherlands
RH Nanopharmaceuticals
Bringing a safer non narcotic non NSAID to the world
DNX Biopharmaceuticals
Pioneering the future of medicine with innovative and long-lasting therapeutic proteins to...
About Protalix Biotherapeutics
Protalix Biotherapeutics is a leading biopharmaceutical company specializing in the development and commercialization of recombinant therapeutic proteins. The company is known for its novel plant cell-based expression system, ProCellEx, which has garnered FDA approval for its protein production. Protalix's flagship pro...
Biopharmaceutical, Recombinant Therapeutic Proteins, ProCellEx, FDA Approval, Taliglucerase Alfa, Pfizer Partnership, Pegunigalsidase Alfa, Fabry Disease, Alidornase Alfa, PRX 110, PRX 115, PRX 119, Chiesi Farmaceutici S.p.A., Pharmaceutical Commercialization, Drug Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Protalix Biotherapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Protalix Biotherapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
